Short QT syndrome AICD placement

Jump to navigation Jump to search

To go back to the main page, click here.

Short QT syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Type 1
Type 2
Type 3
Type 4
Type 5

Pathophysiology

Causes

Triggers

Differentiating Short QT syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

EP studies

Genetic Testing

Treatment

AICD Placement

Medical Therapy

Case Studies

Case #1

Short QT syndrome AICD placement On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Short QT syndrome AICD placement

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Short QT syndrome AICD placement

CDC on Short QT syndrome AICD placement

Short QT syndrome AICD placement in the news

Blogs on Short QT syndrome AICD placement

Directions to Hospitals Treating Short QT syndrome

Risk calculators and risk factors for Short QT syndrome AICD placement

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

An implantable cardioverter-defibrillator (ICD) is indicated in[1]:

  • Patients who survive sudden death and symptomatic patients
  • Patients with a family history of sudden cardiac death

Generally accepted criteria for implantation of an AICD also include:

  • Inducibility on electrophysiologic testing
  • Positive genetic test, although a negative result does not exclude the presence of a previously unreported mutation or the occurrence of a future arrhythmic event

Complications of AICD Placement

Inappropriate shocks may be delivered due to[2]:

References

  1. Borggrefe M. FESC, Wolpert C, Veltmann C, Giustetto C, Gaita F, Schimpf R. Short QT Syndrome : A new primary electrical disease, ESC E journal, Vol 3 N°34, 10 May 2005. [1]
  2. Schimpf R, Wolpert C, Bianchi F, et al. Congenital Short QT Syndrome and Implantable Cardioverter Defibrillator Treatment: Inherent Risk for Inappropriate Shock Delivery. J Cardiovasc Electrophysiol 2003; 14: 1273-1277.